FDA

Thailand pays out roughly $45 million to victims of COVID-19 vaccines so far.

Pfizer CEO Albert Bourla on Sunday said the vaccine maker plans to submit data on a fourth dose of its COVID-19 vaccine to the U.S. Food and Drug Administration because protection after three doses is “not that good against infections” and “doesn’t last very long” when faced with a variant like Omicron.

Pfizer will "no longer initiate new clinical trials in Russia, and we will stop recruiting new patients in our ongoing clinical trials in the country."

COVID-19 vaccines may be causing enhanced disease because they target an old version of the coronavirus, Dr. Robert Malone says.

Cardiologist, professor and frontline doctor Peter McCullough asserts that early COVID-19 testing data indicates the genetic materials in the vaccine could be incorporated into the human genome.

'Corporate media' bought off, and 'the consequence is that many people have needlessly suffered'

Clinical trial data contradicts ‘safe and effective’ government/industry mantra.

Only "researchers, trial participants, regulators, and others" who act in what Pfizer deems to be "the best interest" of patients have access to the pharmaceutical company's clinical trial documents that reveal injuries and deaths from their Covid-19 mRNA drug.

Repurposed drugs that have been shown to prevent or treat COVID-19 may be prescribed by physicians, the Florida Department of Health said in its new COVID-19 guidance for health care practitioners.

Early reports say there are "nine pages" of recorded adverse events, "1,223 reported fatalities during 3-month period."